Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19
Jingjing Li(Hong Kong University of Science and Technology), Lifang Yin(China Pharmaceutical University), Lei Yang(China Pharmaceutical University), Xinyu Chu(China Pharmaceutical University), Yungen Xu(China Pharmaceutical University), Kai Zhang(China Pharmaceutical University), Di Wu(China Pharmaceutical University), Xiaopeng Han(China Pharmaceutical University), Chao Qin(University of Southern California), Taijun Hang(China Pharmaceutical University), Lianjie Ren(China Pharmaceutical University)
Cited by 47
Related Papers
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
|ACS Nano|2018|229
Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
|Scientific Reports|2017|92
Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption
|International Journal of Pharmaceutics|2013|87